Pancreatic Cancer Research

ResearcherOregon Health & Science UniversityActive in the last 2 years

Thomas Lee Sutton

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2894-7154; OpenAlex author ID A5024318099. Sources: OpenAlex.

Their work

Papers
8 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2022: 4 papers · 2023: 3 papers · 2024: 1 paper

Papers 8

  1. Rapid metastatic recurrence after pancreatic cancer resection: a multi-center, regional analysis of trends in surgical failure over two decades. Co-author DOI 10.1016/j.hpb.2024.08.006↗
  2. Socioeconomic and Geographic Disparities in the Referral and Treatment of Pancreatic Cancer at High-Volume Centers. Co-author DOI 10.1001/jamasurg.2022.6709↗
  3. Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. First author DOI 10.1002/jso.27281↗
  4. High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2023.02.012↗
  5. Disparities in pancreatic cancer care and research in Native Americans: Righting a history of wrongs. First author DOI 10.1002/cncr.34118↗
  6. Validation of automated body composition analysis using diagnostic computed tomography imaging in patients with pancreatic cancer. First author DOI 10.1016/j.amjsurg.2022.03.025↗
  7. The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1128/mcb.00018-22↗
  8. Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasin… First author DOI 10.3390/cancers14030609↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brett C. Sheppard · 7 shared papers, 2022–2024 · strength 1.25
  2. Aaron J. Grossberg · 4 shared papers, 2022–2023 · strength 0.64
  3. Ranish K. Patel · 3 shared papers, 2023–2024 · strength 0.57
  4. Skye C. Mayo · 3 shared papers, 2022–2023 · strength 0.47
  5. Charles D. Lopez · 3 shared papers, 2022–2023 · strength 0.47
  6. Flavio G. Rocha · 2 shared papers, 2023–2024 · strength 0.39
  7. Shay Behrens · 2 shared papers, 2023 · strength 0.36
  8. Jonathan Robert Brody · 2 shared papers, 2022 · strength 0.33
  9. Ali Noel Gunesch · 2 shared papers, 2022 · strength 0.29
  10. Christopher R. Deig · 2 shared papers, 2022 · strength 0.29
  11. Pavlos Papavasiliou · 1 shared paper, 2024 · strength 0.21
  12. Patrick Joseph Worth · 1 shared paper, 2024 · strength 0.21
  13. Claymore Kills First · 1 shared paper, 2022 · strength 0.20
  14. Jackilen Shannon · 1 shared paper, 2022 · strength 0.20
  15. Daniel L. Marks · 1 shared paper, 2022 · strength 0.17
  16. Aditi Jain · 1 shared paper, 2022 · strength 0.13
  17. Christopher William Schultz · 1 shared paper, 2022 · strength 0.13
  18. Matthew McCoy · 1 shared paper, 2022 · strength 0.13
  19. Samantha Z. Brown · 1 shared paper, 2022 · strength 0.13
  20. Grace A. McCarthy · 1 shared paper, 2022 · strength 0.13
  21. Rosalie C. Sears · 1 shared paper, 2022 · strength 0.13
  22. Charles J. Yeo · 1 shared paper, 2022 · strength 0.13
  23. Avinoam Nevler · 1 shared paper, 2022 · strength 0.13
  24. Wei Jiang · 1 shared paper, 2022 · strength 0.13
  25. Dan A. Dixon · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.